---
title: "US FDA clears phase 3 clinical study of ASI-02 in patients undergoing TTE"
date: "2025-04-08T16:13:29.000Z"
publishedDate: "8 avril 2025"
summary: "The US Food and Drug Administration (FDA) has cleared Agitated Solutions Incorporated’s (ASI’s) investigational new drug (IND) application for its novel contrast agent, ASI-02, enabling the initiation of the company’s phase 3 clinical trial. This multicentre randomised study will assess the safety and efficacy of ASI-02 in up to 300 patients in the USA and [&#8230;] The post US FDA clears phase 3 clinical study of ASI-02 in patients undergoing TTE appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-clears-phase-3-clinical-study-of-asi-02-in-patients-undergoing-tte/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-04-08-us-fda-clears-phase-3-clinical-study-of-asi-02-in-patients-undergoing-tte"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/04/image002.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-clears-phase-3-clinical-study-of-asi-02-in-patients-undergoing-tte/"
---

![US FDA clears phase 3 clinical study of ASI-02 in patients undergoing TTE](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/04/image002.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-clears-phase-3-clinical-study-of-asi-02-in-patients-undergoing-tte/*

## L’essentiel

The US Food and Drug Administration (FDA) has cleared Agitated Solutions Incorporated’s (ASI’s) investigational new drug (IND) application for its novel contrast agent, ASI-02, enabling the initiation of the company’s phase 3 clinical trial. This multicentre randomised study will assess the safety and efficacy of ASI-02 in up to 300 patients in the USA and [&#8230;] The post US FDA clears phase 3 clinical study of ASI-02 in patients undergoing TTE appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/us-fda-clears-phase-3-clinical-study-of-asi-02-in-patients-undergoing-tte/
